:Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening

An implant in a blood vessel on the surface of the 64-year-old man’s brain let him mentally “tap” icons on an Amazon Fire tablet, says company.

In his tweet, Elon Musk also said that the experimental device would "even enable those who have been blind from birth to see for the first time" provided that the visual cortex is intact.

Musk’s chip implant startup Neuralink has received the ‘breakthrough device’ designation for its Blindsight device, he said on X.

The experimental device, known as Blindsight, "will enable even those who have lost both eyes and their optic nerve to see," Musk said in a post on X.

Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer...

Elon Musk has announced that his company Neuralink has received approval for a brain implant called "Blindsight" that will enable the blind to see again.

The Blindsight device from Elon Musk’s brain-chip startup company Neuralink will enable even those who have lost both eyes and their optic nerve to see.

Neuralink's Blindsight is poised to change the future of vision restoration and brain-computer interfaces. While it’s still in the early stages, the potential impact on people with visual impairments and the broader medical community is immense.